首页> Journal of medicinal chemistry> From High-Throughput Screening to Target Validation: Benzo[<i>d</i>]isothiazoles as Potent and Selective Agonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 5 Possessing In Vivo Gastrointestinal Prokinetic Activity in Rodents.

From High-Throughput Screening to Target Validation: Benzo[<i>d</i>]isothiazoles as Potent and Selective Agonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 5 Possessing In Vivo Gastrointestinal Prokinetic Activity in Rodents.

导出原文传递

翻译打印收藏纠错

第一作者： Alessio,Barilli

第一单位： Aptuit, an Evotec Company, Via Alessandro Fleming, 4, Verona 37135, Italy.

作者： Alessio,Barilli ^[1] ; Laura,Aldegheri ^[1] ; Federica,Bianchi ^[1] ; Laurent,Brault ^[1] ; Daniela,Brodbeck ^[1] ; Laura,Castelletti ^[1] ; Aldo,Feriani ^[1] ; Iain,Lingard ^[1] ; Richard,Myers ^[2] ; Selena,Nola ^[1] ; Laura,Piccoli ^[1] ; Daniela,Pompilio ^[1] ; Luca F,Raveglia ^[1] ; Cristian,Salvagno ^[1] ; Sabrina,Tassini ^[1] ; Caterina,Virginio ^[1] ; Mark,Sabat ^[2]

作者单位： Aptuit, an Evotec Company, Via Alessandro Fleming, 4, Verona 37135, Italy. ^[1] Takeda Pharmaceuticals, 9625 Towne Centre Drive, San Diego, California 92121, United States. ^[2]